Beranda › Kanker Prostat › South Carolina › Myrtle Beach
Uji klinis Kanker Prostat di Myrtle Beach, SC
24 studi untuk Kanker Prostat mencari peserta di lokasi sekitar Myrtle Beach (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
Menerima pesertaFase 3
- Carolina Urologic Research Center, Myrtle Beach
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- MUSC Hematology-Oncology at Murrells Inlet, Murrells Inlet · 13 mi jauhnya
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
Menerima pesertaStudi observasional
- Carolina Urologic Research Center, Myrtle Beach
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Menerima pesertaFase 1
- Carolina Urologic Research Center, Myrtle Beach
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Menerima pesertaFase 1/2
- Carolina Urologic Research Center, Myrtle Beach
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Menerima pesertaFase 1/2
- Research Site, Myrtle Beach
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Menerima pesertaFase 3
- Grand Strand Medical Center, Myrtle Beach
- Carolina Urologic Research Center, LLC, Myrtle Beach
- Parkway Surgery Center, Myrtle Beach
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Menerima pesertaFase 1
- START Carolinas, Myrtle Beach
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Menerima pesertaFase 2/3
- Carolina Urologic Research Center, Myrtle Beach
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Menerima pesertaFase 3
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Menerima pesertaFase 3
- Carolina Urologic Research Center, Myrtle Beach
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Menerima pesertaFase 3
- Research Site, Myrtle Beach
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Menerima pesertaFase 2
- START Carolinas, Myrtle Beach
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Menerima pesertaFase 3
- Carolina Urologic Research Center, Myrtle Beach
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Menerima pesertaFase 2
- Carolina Urologic Research Center, Myrtle Beach
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Menerima pesertaFase 3
- Research Site, Myrtle Beach
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Menerima pesertaFase 2
- Carolina Urologic Research Center, Myrtle Beach
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Menerima pesertaFase 1
- Carolina Urologic Research Center, Myrtle Beach
PSMA PET Combined With MRI for the Detection of PCa
Menerima pesertaFase 3Sukarelawan sehat diterima
- Atlantic Urology Specialists, Myrtle Beach
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Menerima pesertaFase 1
- Carolina Urologic Research Center, the START Center for Cancer Research, Myrtle Beach
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Menerima pesertaFase 1
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Menerima pesertaFase 1
- Carolina Urologic Research Center, Myrtle Beach
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Menerima pesertaFase 3
- Carolina Regional Cancer Center, Myrtle Beach
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Menerima pesertaFase 2
- Carolina Urologic Research Center, Myrtle Beach
Uji klinis Kanker Prostat di kota lain
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN43 studi
- Seattle, WA42 studi
- Washington, DC38 studi
Studi lain di Myrtle Beach
- Kanker Kandung Kemih10 studi
- Kanker Kandung Kemih Non-Invasif Otot9 studi
- Kanker Ginjal (Karsinoma Sel Renal)6 studi
- Karsinoma Urotelial (Sel Transisional)5 studi
- Kanker Metastatik5 studi
- Diabetes Tipe 23 studi
- Kanker Prostat Resisten Kastrasi3 studi
- Kanker (semua jenis)3 studi
- Karsinoma In Situ3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.